LEXEO Therapeutics Announces Upcoming Data Presentations at the ASGCT 2021 Virtual Annual Meeting

Updated: Apr 29

In collaboration with Weill Cornell Medicine's Department of Genetic Medicine, LEXEO Therapeutics, a clinical-stage gene therapy company, today announced

upcoming presentations regarding its investigational gene therapy programs at the American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, taking place virtually from May 11-14, 2021.

LEXEO Announces Upcoming Data Presentati
Download • 65KB